New drug shows promise in early trial for advanced cancers
Disease control
Completed
This early-phase study tested a new drug called NOV140101 in 32 adults with advanced solid tumors that had spread or could not be removed. The main goals were to find the safest dose and check for side effects. Researchers also looked at how the drug moves through the body and wh…
Phase: PHASE1 • Sponsor: Idience Co., Ltd. • Aim: Disease control
Last updated May 01, 2026 16:01 UTC